Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
32.08
-0.31 (-0.96%)
Apr 29, 2026, 9:32 AM EDT - Market open
Viking Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,718 | 3,977 | 4,484 | 1,862 | 721 | 360 | |
| Market Cap Growth | 49.07% | -11.32% | 140.89% | 158.23% | 100.31% | -12.38% | |
| Enterprise Value | 3,048 | 3,263 | 3,555 | 1,487 | 567 | 144 | |
| Last Close Price | 32.39 | 35.18 | 40.24 | 18.61 | 9.40 | 4.60 | |
| PB Ratio | 5.82 | 6.22 | 5.09 | 5.34 | 4.96 | 1.78 | |
| P/TBV Ratio | 5.87 | 6.22 | 5.09 | 5.34 | 4.96 | 1.78 | |
| Debt / Equity Ratio | 0 | 0 | 0.00 | 0.00 | 0.01 | 0 | |
| Net Debt / Equity Ratio | -1.10 | -1.10 | -1.02 | -1.04 | -1.06 | -1.00 | |
| Quick Ratio | 9.21 | 9.21 | 32.93 | 18.92 | 7.09 | 23.02 | |
| Current Ratio | 9.33 | 9.33 | 33.09 | 19.19 | 7.61 | 23.98 | |
| Return on Equity (ROE) | -47.34% | -47.34% | -17.90% | -34.79% | -39.67% | -24.65% | |
| Return on Assets (ROA) | -30.28% | -30.28% | -14.77% | -23.47% | -23.19% | -14.90% | |
| Return on Capital Employed (ROCE) | -61.50% | -61.50% | -17.10% | -28.90% | -48.00% | -27.60% | |
| Earnings Yield | -9.58% | -9.04% | -2.45% | -4.61% | -9.55% | -15.28% | |
| Buyback Yield / Dilution | -3.33% | -3.33% | -15.57% | -22.79% | 0.47% | -6.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.